Binding of heparin and of the small proteoglycan decorin to the same endocytosis receptor proteins leads to different metabolic consequences by unknown
Binding ofHeparin and of the Small Proteoglycan
Decorin to the Same Endocytosis Receptor Proteins
Leads to Different Metabolic Consequences
Heinz Hausser and Hans Kresse
Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, D-4400 Münster, Germany
Abstract. Decorin, a small interstitial dermatan sul-
fate proteoglycan, is turned over in cultured cells of
mesenchymal origin by receptor-mediated endocytosis
followed by intralysosomal degradation. Two en-
dosomal proteins of 51 and 26 kD have been impli-
cated in the endocytotic process because of their inter-
action with decorin core protein. However, heparin
and protein-free dermatan sulfate were able to inhibit
endocytosis of decorin in a concentration-dependent
manner. After Western blotting of endosomal proteins,
j/J)
DCORIN (small dermatan sulfate proteoglycan II) is a
member of the family of small interstitial proteo-
glycans (14, 28). It has been found in all tissues so
far investigated (43) . The mature molecule consists of a core
protein with a relative molecular mass of 36,319 as deduced
from cloned cDNA (18), a single glycosaminoglycan chain
linked to the serine residue at position 4 (4) and either two
or three asparagine-bound oligosaccharides (9). The central
part ofthe core protein is made up by 10 leucine-rich repeats.
Similar repeats have been found in several other proteins, for
example in the leucine-rich a2-glycoprotein of human se-
rum (27, 38) the platelet glycoprotein Ib (24), the humancar-
boxypeptidase N high molecular weight subunit (39), and
have been implicated in protein-protein interactions.
Interactions ofdecorin with several components of the ex-
tracellular matrix have been demonstrated. Through its core
protein it bindsto types I and II collagen (33, 34, 35), there-
by affecting fibril formation (13, 42). Decorin core protein
is also responsible for an interaction with fibronectin (32)
which may lead to an inhibition of fibroblast adhesion to fi-
bronectin substrates (21, 44). Recently, a role of decorin in
the control ofcell proliferation has been suggested (46), pos-
sibly by its ability to bind to transforming growth factor-ß
(45).
Therefore, theregulationofthe extracellular concentration
of decorin by the rates of its biosynthesis and of its degrada-
tion seems to be of great physiological importance. It has
been shown that under tissue culture conditions a significant
portion of secreted decorin is recapturedby the cells and de-
graded in the lysosomes (31). The protein moiety of decorin
is responsible for its uptake by receptor-mediated endocy-
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there was competition for binding to the 51- and 26-
kD proteins between heparin and decorin. In spite of
its high-affinity binding, heparin was poorly cleared
from the medium of cultured cells and then catabo-
lized in lysosomes. In contrast to decorin, binding of
heparin to the 51- and MAD proteins was insensitive
to acidic pH, thus presumably preventing its dissocia-
tion from the receptor in the endosome. Recycling of
heparin to the cell surface after internalization could
indeed be demonstrated.
tosis(27, 40) . Lysine and arginine residues have been shown
to be important for the uptake properties (8), although the
structure of the receptor-binding domain of the core protein
is not yet known. Endosomal proteins of 51 and 26 kD have
been shown tohave decorin-bindingpropertiesand were con-
sidered as putative components of the decorin endocytosis
receptor on the basis ofthe following additional findings (12) .
They co-precipitated with a proteoglycan core protein-anti-
body complexand showed strongbinding to immobilized der-
matan sulfateproteoglycan. Furthermore, they were sensitive
to trypsin treatment of intact cells suggesting their presence
on the cell membrane. In this report it will be shown that
heparin and some other highly sulfated glycosaminoglycans
are also interacting with these proteins and may serve as in-
hibitors ofdecorin uptake by cultured fibroblasts. In spite of
the high affinity binding ofheparin, however, its rate of endo-
cytosis is at least a magnitude lower than that of decorin
which might be explained by the stability of the heparin-
receptor complex at acid pH.
Materials and Methods
Materials
The human osteosarcoma cell line MG-63 was obtained from the American
TypeCulture Collection (Bethesda, MD). Rabbit antiserum against decorin
core protein wasobtainedas described previously (9). Goat antibody against
rabbit IgG conjugated with horseradish peroxidase was from Bio-Rad (Mu-
nich, Germany) . Thefollowing materials werepurchasedfromthe suppliers
indicated: [N-sulfonate-35S]heparín (8,000 M) and sodium [35S]sulfate(car-
rier free) (Amersham-Buchler GmBH, Braunschweig, Germany); heparin-
Sepharose CL-6B I % (Pharmacia Fine Chemicals, Freiburg, Germany; nitro-
45cellulose membranes (BA 83, 0.2 km), (Schleicher and Schuell, Dassel,
Germany); chondroitin ABC lyase 1% (Seikagaku Kogyo, Tokyo, Japan);
heparin from hog intestinal mucosa and dextran sulfate 500 1% (Serva,
Heidelberg, Germany); chondroitin-4-sulfate and chondroitin-6-sulfate, so-
dium deoxycholate, pepstatin A, leupeptin, and trifluoromethane sulfonic
acid 1% (Sigma Chemical Co., Deisenhofen, Germany).
Decorin was prepared from the secretions of human skin fibroblasts by
anion-exchange chromatography on a Bio-Gel TSK DEAE-5 PW HPLC
column as described previously (12). [35S]Sulfate-labeled decorin was pre-
pared analogously after incubation of fibroblasts in the presence of 0.37
MBq/ml of [35S]sulfate for 72 h. In these incubations streptomycine sesqui-
sulfate was omitted, and FCS, dialyzed against 0.15 M NaCl, was added
to a final concentration of 4% (vol/vol).
Decorin-derived glycosaminoglycan chains were obtained after a
ß-elimination reaction. Theproteoglycan was adjusted to0.15 M NaOH/1 M
NaBH4 and incubated for 18 h at 37°C. The reaction was stopped by add-
ing 1 M acetic acidtopH 5. The solution was made 10% (vol/vol) with FCS
and dialyzed against endocytosis medium (see below).
Dermatan sulfate fractions differing in their iduronic acid content were
obtained from bovine skin as described (7) . Crude glycosaminoglycans
were dissolved in 0.25 M acetic acid containing 0.14 M calcium acetate and
subjected to differential ethanol precipitation. The iduronic acid-rich frac-
tion precipitating at an ethanol concentrationof 18% (vol/vol) was subjected
to a O-elimination reaction as described above. After neutralization, the re-
action mixture was dialyzed against 20 mM Tris/HCI, pH 7.4, containing
0.15 M NaCl and chromatographed on a DEAETrisacryl column (Serva,
Heidelberg, Germany) asdescribed previously (9). The glycosaminoglycan
fraction was dialyzed against water and lyophilized. Heparan sulfate from
bovine aorta was obtained as described previously (27) .
PreparationofDecorin/Heparin-bindingProteins
Subcellular fractions enriched in endosomes were prepared from osteosar-
coma cells as described previously (12). For Western blotting experiments,
the sucrose gradient step was occasionally omitted. In these cases, the ve-
sicular fraction of the post-mitochondrial supernatant was spun down by
centrifugation for 1 h at 105,000 g at 4°C and then dissolved in sample
buffer (19).
Furtherpurification ofbinding proteins was achievedon a heparin-Seph-
arose CL-6B column. Approximately 500 gg of endosomal proteins were
dissolved in 0.1 M Tris/HCI buffer, pH 7.4, 0.5% (wt/vol) Zwittergent 3-12,
10.1 AM leupeptin, and 7.3 AM pepstatin A (buffer A) containing 0.15 M
NaCl and applied to a 4-ml column of the affinity matrix which had been
equilibrated with the same buffer. After washing the column with 20 ml of
this buffer, a linear gradient of 40 ml of 0.15-1 M NaCl in buffer A was
applied. Fractions of 1.15 ml were collected, concentrated to a volume of
about 100A1 ina Speed Vac concentrator (Bachofen, Reutlingen, Germany),
and proteins wereprecipitated at 4°C by addition of 200 141 of 17% (wt/vol)
TCA . The precipitated material was washed with 500 Al of methanol and
dissolved in sample buffer as above.
BindingExperiments
Decorin and heparin binding was studied after SDS-PAGE (19, as modified
in 11) followed by Western blotting onto nitrocellulose membranes (37). Af-
ter blotting, the membranes were rinsed with 20 mM Tris/HCl buffer, pH
7.4, containing 0.15 M NaCl (buffer B) and incubated overnight at 4°C with
3% (wt/vol) BSA in this buffer (blocking solution) . The buffer was then re-
placed by fresh buffer containing additionally 1-5 x 105 cpm/nil of either
[35S]sulfate-labeled decorin or heparin. Binding was allowed to occur over
a period of 60-90 min at ambient temperature. The membranes were then
washed seven times for 5 min each with buffer B, dried, and exposed for
autoradiography to a preflashed Kodak X-OMAT AR film (Eastman Kodak
Co., Rochester, NY) at -80°C.
Immunochemical evidence for binding was obtained as follows. After
Western blotting and treatmentwith blocking solution, nitrocellulosemem-
branes were incubated with decorin, decorin coreproteins, and deglycosyl-
ated core protein, respectively, at a concentration of -0.3 nmoles/ml in
blocking solution. The membrane was washed with buffer B and further
processed by successive incubations with rabbit-antidecorin core protein
antiserum, diluted 1:500 inblocking solution, and goat-antirabbit IgG anti-
body conjugated with HRP, diluted 1:1,000 in blocking solution. Staining
was in buffer B/methanol (5:1, vol/vol), containing 2.8 mM 4-chloro-l-
naphtol and 4.9 MM H202.
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Endocytosis
Endocytosisby culturedhuman skinfibroblasts ofdecorin, dermatan sulfate,
and heparin, respectively, was determined exactly as described (8). A pH
of 7.2 was maintained by lowering the NaHC03 concentration of the cul-
ture mediumto 1.6 g/1 andby addition of 10 mM N-(2-hydroxyethyl) pipera-
zine-N'-2-ethanesulfonic acid. Since endocytosis of proteoglycans and gly-
cosaminoglycan chains is followed by intralysosomal degradation and
concomitant release of inorganic sulfate into the culture medium, endocy-
tosis of [35S]sulfate-labeled macromolecules is represented by the sum of
intracellular radioactivity and ethanol-soluble radioactivity in the culture
medium. Degradation is defined as the sum of the intra- and extracellular
amount of ethanol-soluble radioactivity over the total amount of endocy-
tosed material.
To follow the recycling of internalized heparin, cells were washed twice
with calcium-free HBSSandonce with PBS, both prewarmed to 37°C. Cells
were then incubated for 90 min at 37°C with [N-sulfonate-35S]heparin in
PBS containing additionally 1% (wt/vol) BSA. Afterwashing the cells three
times with PBS precooled to 4°C, surface-bound heparin was desorbed in
the cold by three washes, for 20 min each, with PBS containing 100 Ag/ml
of nonradioactive heparin. Finally, cells were returned to 37°C by a short
wash withprewarmed PBS, and then incubated for 30 min at 37°C with PBS
containing 100 Ag/ml ofunlabeled heparin. In control incubations, the last
steps were performed at 4°C. Intracellular radioactivity was then obtained
by dissolving the cell layer in 1 M NaOH and neutralization with 1 ml of
1 M acetic acid.
OtherMethods
Enzymatic digestion of decorin with chondroitin ABC lyase (30) was per-
formed exactly as described. Deglycosylation ofdecorin core protein with
trifluoromethane sulfonic acid was performed according to Sojar and Bahl
(36), 33.3% (vol/vol) of anisol was included in the reaction mixture. Hex-
uronic acids (1) and protein (2) were quantitated as stated previously. Silver
staining of SDS-polyacrylamide gels was performed according to Merril
et al . (26).
Results
Binding ofHeparin toDecorin-receptorProteins
Previous work has shown that intact decorin binds to endo-
somal proteins of51 and 26 kD and that glycosaminoglycan-
free core protein is able to inhibit this interaction (12). It has,
therefore, been postulated that the interaction ofdecorin with
the 51- and 26-kD proteins is mediated via the protein moiety
ofthe proteoglycan. However, the binding oftheisolated core
protein had not yet been demonstrated directly. Since it will
be shown below that highly negatively charged glycosami-
noglycans bind to these receptor proteins, too, it seemed
necessary to verify the proposal of a core protein-receptor
interaction by a more direct method. With the aid of a mono-
specific antiserum against decorin core protein, binding of
intact decorin, of glycosaminoglycan-free core protein and
of completely deglycosylated core protein could indeed be
demonstrated qualitatively on a Western blot of endosomal
proteins from osteosarcoma cells (Fig. 1) . From the results
of several experiments it appeared that the intact and the
chondroitin ABC lyase-degraded proteoglycan exhibited sim-
ilar binding properties. However, treatment with trifluoro-
methanesulfonic acid, which led to the appearance of the
carbohydrate-free core protein of 36 kD (result not shown),
had a negative influence on the binding properties. There
was only weak binding to the 26-kD protein, but additional
binding to a 28-kD protein. This observation has not yet
been studied further. It seems possible that oligosaccharides
are involved in binding to the 26ÁD protein. In previous
studies, however, no indication was obtained for the involve-
46Figure 1 . Indirect immunostaining ofdecorin-binding proteins . In-
tact decorin, decorin core protein, and deglycosylated core protein,
respectively, were allowed to bind to blotted endosomal proteins .
Binding was demonstrated by immunostaining with an anti-decorin
core protein antiserum and anti-IgG conjugated to HRP ABC,
treatment with chondroitin ABC lyase ; TFMS, treatment with tri-
fluoromethane-sulfonic acid .
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ment of oligosaccharides in the endocytotic process (8) . Sev-
eral other proteins with decorin-binding properties that are
seen in Fig . 1 are probably derived by proteolysis during
preparation of the endosomes (12) .
Surprisingly, binding of decorin to the 51- and 26-kD-pro-
teins could be strongly inhibited by several glycosaminogly-
cans (Fig . 2) . Ata dose of 10 pg/ml, heparin and dextran sul-
fate abolished binding almost completely. Dermatan sulfate
was somewhat less effective, but chondroitin-4-sulfate occa-
sionally even enhanced decorin binding . The undersulfated
heparan sulfate (0.7 pmol sulfate/umol hexuronic acid) was
slightly inhibitory.
Direct binding of ["S]sulfate-labeled heparin to endoso-
mal proteins demonstrated an interaction of this polyanion
with the 51- and 26-kD proteins and with a variety of other
proteins (Fig . 3) . There was no effective competition for hep-
arin binding by several other glycosaminoglycans including
dermatan sulfate and heparan sulfateat the doses used. When
the 51-kD protein on a Western blot of endosomal proteins
was first incubated with [35S]sulfate-labeled decorin, unla-
beled heparin (5 hg/ml) released 38% of bound radioactivity
within 5 min, and 77 °k within 15 min . In a different experi-
mental approach, solubilized endosomal proteins were chro-
matographed on a heparin-Sepharose CL-6B column (Fig .
4) . Adsorbed proteins were eluted by applying a linear gradi-
ent from 0.15-1.0M NaCl . The 26-kD protein was desorbed
at an NaCl concentration of about 0.5M and the 51-kD pro-
tein at anNaCI concentration of about 0.7 M . Decorin-bind-
ing proteins eluting at a lower salt concentration were not
found .
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Figure 2 . Effect of different glycosaminoglycans on
decorin binding to endosomal proteins . 20 ug of en-
dosomal proteins from human MG-63 osteosarcoma
cells were subjected toSDS-PAGEunder nonreducing
conditions and Western blotting. Binding of 1 35S]sul-
fate-labeled decorin was performed either in the ab-
sence (lane 1) or presence of 10 lg/ml ofthe following
glycosaminoglycans : heparin (lane 2), heparan sulfate
(lane 3), fl-eliminated dermatan sulfate chains (lane
4), chondroitin-4-sulfate (lane S), and dextran sulfate
(lane 6) .Figure 3 . Binding of heparin to endosomal proteins . 30 pg of en-
dosomal proteins were blotted onto nitrocellulose as described in the
legend of Fig . 1 and incubated with [N-sulfonate-35S]heparin either
in the absence (lane 1) or presence of 10 ug/ml of the following
glycosaminoglycans : heparin (lane 2), heparan sulfate (lane 3),
ß-eliminated dermatan sulfate chains (lane 4), chondroitin-6-sul-
fate (lane 5), and chondroitin-4-sulfate (lane 6) .
Inhibition ofDecorin Endocytosisby Heparin
The binding of heparin to decorin receptor proteins suggested
an inhibitory effect of heparin on the uptake of the proteo-
glycan by intact cells . Indeed, endocytosis of [ 35S]sulfate-
labeled decorin could be inhibited in part by low concentra-
tions ofheparin (Fig . 5) . A minor inhibitory effect was found
for iduronic acid-rich dermatan sulfate, too . Exposing the
cells for 6 h to labeled decorin (750,000 cpm/ml), heparin
(10 p,glml) led to an inhibition of decorin uptake by 48%,
and iduronic acid-rich dermatan sulfate chains at the same
concentration by 12% . In the presence of chondroitin-4-sul-
fate, decorin endocytosis remained unaltered .
EndocytosisofHeparin
The high-affinity binding of [35S]sulfate-labeled heparin to
endosomal proteins let us assume a high rate ofendocytosis
ofthis polysaccharide by fibroblasts . A comparative study of
the uptake of heparin and decorin, however, indicated that
decorin is endocytosed at least 30 timesmore efficiently than
heparin (Fig . 6) . Endocytosis of decorin is followed by trans-
port to lysosomes and intralysosomal degradation . In the ex-
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periment described in Fig . 6, 75-79% of the endocytosed
proteoglycan had been degraded asjudged by the appearance
of inorganic [35S]sulfate . On the contrary, only 8-10% of
endocytosed heparin had been depolymerized .
Dermatan sulfate chains are even less efficiently endocy-
tosed than heparin . When cells were allowed to endocytose
either decorin or dermatan sulfate chains derived from the
same decorin preparation by ß elimination, the clearance
rates were 95.2 pl/h andmg cell protein for decorin and only
0.8 p,l/h and mg for dermatan sulfate .
pH Insensitivity ofHeparinBinding
toEndosomalProteins
In an analogous experiment as that described in Fig . 3, en-
dosomal proteins were exposed to [35S]sulfate-labeled hepa-
rin atpH 7.4 . Subsequent incubation at pH 4.0 did not result
in a measurable release of bound ligand (Fig . 7) . This is in
sharp contrast to the behavior of bound decorin which is al-
most completely released at acid pH (12) .
ReplacementofInternalized Heparin
The results described in the previous sections suggest that
heparin could be bound by a high-affinity endocytosis recep-
tor, but is not released from the receptor at the pH being
present in the compartment of uncoupling of receptor and
ligand (CURL) . It seemed, therefore, possible that internal-
ization of heparin is followed by its reappearance at the plas-
ma membrane. To test this hypothesis, fibroblasts were ex-
posed to [3'S]sulfate-labeled heparin at 37°C . The cells were
then treated at 4°C with an excess of unlabeled heparin to
exchange labeled ligand at theplasma membrane. Further in-
cubation was again at 37°C in the presence of unlabeled
heparin . It is shown in Fig . 8 that, depending on the dose
oforiginally applied heparin, 40-90% ofinternalizedheparin
reappeared at the plasma membrane and could be desorbed
by unlabeled heparin .
Discussion
The results described in this communication provide direct
evidence that the core protein of the small proteoglycan de-
corin is interacting with the 51- and 26-kD proteins which
are involved in receptor-mediated endocytosis of decorin .
The pI value of9.8 for the unsubstituted decorin core protein
is remarkably high (18) . It was, therefore, unexpected that
the polyanion heparin bound to the same proteins . Though the
presence of an acidic domain found in the tertiary structure
ofdecorin core protein, which binds to the same site as hep-
arin, could not be excluded, it appears more likely that hep-
arin and decorin core protein are bound by adjacent sites
on the receptor proteins . Adjacent binding sites for decorin
core protein and heparin have been proposed to exist on the
NHZ- and COOH-terminal heparin-binding domains of fi-
bronectin (32) .
Competition experiments suggested that other glycosami-
noglycans than heparin could interact with the 51- and 26-kD
proteins . Undersulfated heparan sulfate was only slightly ef-
fective, butheparan sulfate from fibroblasts contains heparin-
like domains (41) which should bind more strongly to these
proteins . Dermatan sulfate was an effective inhibitor of de-
corin binding . Nevertheless, the glycosaminoglycan moiety
48of decorin should play only a minor functional role in medi-
ating the endocytosis of the proteoglycan . Free dermatan
sulfate chains were only slightly inhibitory for decorin up-
take, and their clearance rate amounted to as little as 1% of
that of decorin (this paper, and 27) .
It had been shown previously that heparan sulfate can be
internalized by fibroblasts in a dose-dependent and satura-
ble manner, albeitmuch less efficiently than decorin (17) . To
our knowledge, studies on the endocytosis of heparin by
fibroblasts have not been published in the literature . Vascular
smooth muscle cells were able to internalize a minor propor-
tion of surface-bound heparin . After initial rapid uptake, the
rate sloweddown substantially (3) . Clearance and degrada-
tion rates, however, had not been given . Our data suggest
that the low efficiency ofheparin uptake does not result from
its low affinity to receptor proteins but from the stability of
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Figure 4 . Heparin-affinity-chromatography of en-
dosomal proteins . Endosomal proteins from MG-
63 osteosarcoma cells were subjected to chroma-
tography on a heparin-Sepharose CL-6B column .
Proteins eluted from the column at the indicated
NaCl concentrations were separated by SDS-PAGE
and either stained with AgN03 or, after blotting
onto nitrocellulose, incubated with [35S]sulfate-
labeled decorin . Arrows indicate 51- and 26-kD
proteins, respectively.
the receptor ligand complex at acid pH . Thus, heparin ap-
pears to be transported along the recycling endocytic path-
way in intact cells similarly to the transport of transferrin (5,
16) . Consequently, after internalization of heparin the poly-
saccharide reappears on the cell surface and can be desorbed
by an excess of exogenously added heparin . Decorin, on the
contrary, binds to the same receptor proteins but is trans-
ported along the lysosomal endocytic pathway and becomes
degraded to its monomeric constituents .
It shouldbe noted that a small proportion ofheparin is also
transferred to lysosomes . From the results of the experiment
designed to demonstrate heparin recycling, it appears likely
that heparin-binding proteins ofhigh affinity are responsible
for the recycling pathway and those of lower affinity for the
endocytic pathway.
The major unresolved question raised by the present data
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Figure 5. Inhibition of the endocytosis of decorin by heparin and
dermatan sulfate. Human skin fibroblasts were incubated for 6 h
with [35S]sulfate-labeled decorin (750,000 cpm/ml for inhibition
by dermatan sulfate, 100,000 cpm/ml for inhibition by heparin) in
the presence ofthe indicated concentrations ofß-eliminated derma-
tan sulfate chains (e) and heparin (m), respectively .
concerns the biological relevance of the competition ofdeco-
rin and heparin for binding to the same receptor proteins .
Heparin is certainly only a minor component in the extracel-
lular matrix, and there is a wealth of heparin-binding pro-
teins (see 22, 23, and 29 for reviews) which include several
extracellular matrix proteins and growth factors in addi-
tion to plasma-derived proteins . This multitude of proteins
should compete for heparin binding with the receptor pro-
teins . As stated above, heparin-like heparan sulfate fractions
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Figure 7 . pH sensitivity of heparin binding to endosomal proteins .
Western blots of endosomal proteins were incubated with [N-
sulfonate-3'S]heparin at pH 7.4 and washed five times for 5 min
each with 20 mM Tris/HCl, pH 7.4, containing 0.15M NaCI (lane
1), or with 50 mM sodium acetate, pH 4 .0, containing 100 mM
NaCl (lane 2) .
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Figure 6. Endocytosis of decorin and hepa-
rin by human skin fibroblasts . Cells were in-
cubated for 24 h with ['SS]sulfate-labeled
decorin (N5 .8 x 166 cpm/nmole) and [N-
sulfonate-'SS]heparin (-2 .3 x 106 cpm/
nmol), respectively. (e) heparin ; (0) de-
corin .q
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Figure 8. Recycling ofendocytosed heparin. Cells were allowed to
bind and internalize [N-sulfonate-35S]heparin at 37°C for 90 min.
The cells were cooled to 4°C, and surface-bound ligand was
desorbed by an excess of unlabeled heparin. Cells were then
warmed to 37°C and incubated for 30 min at this temperature in
the presence of unlabeled heparin, competing for labeled heparin
reappearing at the cell surface (o) . Control cellswere kept at 4°C
during this final desorption step (o). The portion of removable
heparin over the total amount of heparin is shown.
could be expected also to serve as competitors for bind-
ing. The existence ofmembrane-intercalated and -associated
heparan sulfate proteoglycans (15, 25) could facilitate the
complex formation with the receptor. Sincea heparan sulfate
core protein carries several glycosaminoglycan chains and
participates in the transmembrane linking of intracellular
cytoskeletal components to extracellular matrix constituents
(20) it couldpossibly retard the movement ofthe endocytosis
receptor into intracellular compartments. In preliminary ex-
periments we observed indeed that enzymatic removal of
heparan sulfate from the cell surface facilitated subsequent
uptake of decorin. Membrane-associated heparan sulfate
could, therefore, be involved in the regulation of decorin
turnover. On the other hand, the presence of decorin-binding
proteins in the extracellular matrix can also interfere with
decorin uptake (10, 31). Further studies are needed to eluci-
date the complex interactions between decorin and hepa-
rin/heparan sulfate and the endocytosis receptor.
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